About
Molecular genetic services
Areas of Focus
Categories
Clinical ResearchServices
Clinical Trials (16)
View allTotal Trials
16
As Lead Sponsor
13
As Collaborator
3
Total Enrollment
603
By Phase
PHASE2: 2NA: 1PHASE1/PHASE2: 6PHASE1: 1
By Status
COMPLETED: 7RECRUITING: 3UNKNOWN: 3ACTIVE_NOT_RECRUITING: 3
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
Today
Hover over trial bars to see details
Recent Trials
NCT06518005Lead Sponsor
Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
PHASE2Recruiting
3 participants
Started: Nov 8, 2024 · Completed: Sep 30, 2030
NCT04940572Collaborator
Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome
PHASE2Recruiting
23 participants
Started: Nov 26, 2021 · Completed: Dec 1, 2025
NCT03842878Lead Sponsor
Natural History Study of Patients With Limb-Girdle Muscular Dystrophy 2I
N/AUnknown
52 participants
Started: Feb 19, 2020 · Completed: Dec 30, 2023
NCT03882827Lead Sponsor
Natural History of Duchenne Muscular Dystrophy
N/AUnknown
100 participants
Started: Dec 19, 2019 · Completed: Jun 30, 2023
NCT03466463Lead Sponsor
Gene Therapy for Severe Crigler Najjar Syndrome
NARecruiting
17 participants
Started: Mar 19, 2018 · Completed: Mar 30, 2030
Locations (1)
Headquarters
Rome, Italy
Map
Loading map...